OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
The company announce its plans to invest $7 million in the expansion of the Westborough, MA facility.
On Oct. 31, 2016 GE Healthcare announced a $7 million expansion project at the company’s single-use technology manufacturing facility in Westborough, MA. The expanded site will manufacture a range of single-use products, including cell growth bags. The investment will triple GE’s production-dedicated cleanroom capacity and upskill more than 300 personnel. The new film platform, developed in collaboration with Sealed Air expressly for biomanufacturing, supports cell growth and application robustness. It will be used in the manufacture of all single-use products at the Westborough site.
“Biopharmaceuticals are complex to make, requiring a dependable, consistent supply of high quality manufacturing technologies. Single-use is top of mind for our customers, for its ability to flex production to meet market needs,” Jan Makela, General Manager, BioProcess at GE Healthcare’s Life Sciences business said in a statement. “The launch of our new film with Sealed Air, the investment in single-use manufacturing in Westborough, MA, and the enlarged E&L capabilities in Sweden confirm our ongoing commitment to minimizing risk and assuring security of supply for our customers around the globe. Our enhanced position in single-use bioprocessing ensures we are fully prepared to support the industry’s rapid growth.”
Source: GE Healthcare